Household Mold Can Trigger Lung Disease
By Dennis Thompson HealthDay Reporter

MONDAY, July 14, 2025 — Household mold can be a significant trigger for a rare but potentially debilitating lung disease that can cause permanent breathing problems, a new study says.
Mold appears to be the primary cause for nearly a quarter (23%) of 231 cases of hypersensitivity pneumonitis (HP) treated at the University of Texas Southwestern Medical Center in Dallas, researchers report in the journal PLOS One.
It’s the largest study to date linking home mold exposure to HP, researchers said. HP is an interstitial lung disease, a group of diseases that irritate, inflame or scar lung tissue.
“This case series is important because it links home mold exposure with the development of hypersensitivity pneumonitis, which informs our efforts to diagnose and treat interstitial lung diseases,” lead author Dr. Traci Adams, an assistant professor of internal medicine at UT Southwestern, said in a news release.
The results also are especially timely given the growing number of extreme weather events caused by climate change, which increase the risk of household mold growth, researchers noted.
HP occurs when repeated exposure to inhaled allergens triggers an immune response that damages lung tissue, researchers said in background notes.
More than 300 substances are known to cause HP, according to the American Lung Association. Some varieties of HP have names based on the source of the allergen.
These include farmer’s lung, from mold on hay, straw and grain; bird fancier’s lung, from avian feathers or droppings; humidifier lung, fungus growing in humidifiers or AC units; and hot tub lung, from bacteria found in steam coming off hot tubs.
For this new study, researchers analyzed records of 231 HP patients between 2011 and 2019, and found that 54 developed the disease due to mold growth in their homes.
Water damage was the primary source of mold growth, most often found in bathrooms, bedrooms and air-conditioning units, researchers said.
Among the 41 patients who removed the source of the mold following its discovery, about 12% showed significant improvement in their lung function within three to four months, the study found.
The patients maintained these gains for at least a year, although four of the five cases involved fibrotic HP, in which improvement is less common due to irreversible scar tissue, researchers said.
Median survival for mold-related HP patients who didn’t receive a lung transplant was about 97 months, comparable to survival outcomes for patients who got HP from mold exposure or bird exposure outside the home, researchers said. (Median means half lived longer, half for a shorter time.)
Identifying mold exposure and using minimally invasive tests like bronchoscopy might help doctors diagnose HP without requiring a surgical biopsy, researchers said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-15 00:00
Read more

- IBS Rates Nearly Doubled During the Pandemic
- Chicken Alfredo Meals Recalled After Listeria Outbreak Kills 3
- Studies Address Muscle Loss Caused By GLP-1 Drugs, such as Ozempic and Zepbound
- RFK Jr. Cancels Key U.S. Health Panel Meeting Without Warning, Raising Concerns
- Mismatch Repair Germline Pathogenic Variants Could Predispose to Uveal Melanoma
- Novo Nordisk's Mim8 Prophylaxis Treatment Shown to be Well-Tolerated When Switching from Emicizumab in People with Hemophilia A in New Phase 3 Data
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions